Gavin Lumsden is a journalist at Citywire. With a 25-year career, he specializes in finance, investment, and real estate, covering topics such as alternative investments, asset management, and renewable energy. He has been featured in prominent outlets including Yahoo News UK, The Telegraph, and QuotedData.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Gavin Lumsden's coverage predominantly focuses on investment analysis and data citations. He is likely to be most receptive to pitches that provide in-depth analysis of investment trusts, stock market trends, financial performance insights, mergers and acquisitions within the business industry, and expert opinions on rate cuts.
Given his focus on finance & economy, business & industry, as well as real estate industries with a specific emphasis on investment trusts and stock markets, he may appreciate commentary from analysts or experts who can offer unique perspectives backed by reliable data.
When pitching to Gavin Lumsden it would be beneficial to reference recent market trends or specific companies' financial performances while keeping the geographic focus broad due to the nature of his topics covered.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Gavin Lumsden
A difficult first half for JPMorgan American (JAM) has not dented the optimism of its fund managers who say the growing opportunities from artificial intelligence (AI) and the resilience of the US economy bode well for the future. The £2bn investment trust, which owns the managers’ 20 best “growth” and 20 top “value” stocks in […]
By: Gavin Lumsden
Scottish Mortgage Trust (SMT) rose 2.2% yesterday after its fund managers’ faith in Moderna was rewarded with a near trebling in the drug developer’s shares. Moderna (MRNA) soared 177%, or $111, to $174.38, valuing the company at more than $60bn, after a late-stage trial showed its individualised cancer therapy intisemeran was successful in treating melanoma […]
By: Gavin Lumsden
Temple Bar (TMPL), the best performing UK equity income investment trust over five years, fell behind the FTSE All-Share in the first half of the year but has since pulled ahead of its benchmark, half-year results show. The £1.3bn closed-end fund recovered from the shock of the Iran war and the spike in oil prices […]
By: Gavin Lumsden
Global Opportunities Trust (GOT), the £97m defensive global equities fund run by Dr Sandy Nairn at Goodhart Partners, made a 1.5% total investment return including its dividend in the first half of the year. Excluding the 10.3p per share final dividend paid in May, the portfolio’s net asset value (NAV) fell 1.1% to 397.3p per […]
By: Gavin Lumsden
Gore Street Energy Storage (GSF) has urged shareholders to vote against the wind-down resolutions tabled by Saba Capital and announced the sale of the first two assets as part of the battery fund’s recovery programme. Chair Angus Gordon Lennox warned that the two resolutions the activist hedge fund requested last month be added to the […]
By: Gavin Lumsden
Schroder Real Estate (SREI) says Peter Lowe, head of UK Real Estate Investment at Schroders Capital, will replace Nick Montgomery as lead manager once the its joint acquisition of Picton Property (PCTN) with LondonMetric (LMP) completes. Montgomery, who was promoted to Global Head of Real Estate at Schroders, will support Lowe for as long as […]
By: Gavin Lumsden
Glenstone, the 25.4% shareholder in Alternative Income REIT (AIRE), says it will resume its push for a managed wind-down of the real estate investment trust if its takeover offer fails, casting doubt on the “subscale” company’s dividend prospects. With two weeks to go until the deadline for acceptances for its £56.3m cash offer, Glenstone REIT […]
By: Gavin Lumsden
Golden Prospect Precious Metals (GPM), the £92m gold mining fund preparing to move to Baker Steel from CQS Manulife, scored a hit with its big share buybacks in the first half of the year. Interim results today show the investment company suffered a 13.6% slide in net asset value (NAV) in the six months to […]
By: Gavin Lumsden
Activist hedge fund Saba Capital lifted its stake in Syncona (SYNC) from 10% to 11.3% last Wednesday, according to a filing on Friday. Shares in the £659m Guernsey-based life sciences fund stand on a 26% discount below net asset value (NAV) having fallen 43% over five years, although they have gained 15% in the past […]
By: Gavin Lumsden
Baillie Gifford US Growth Trust (USA) has received a requisition notice from Saba Capital Management, the activist hedge fund holding 29% of its shares. New York-based Saba has put forward Jason Chen, Thomas H McGlade and James Waterlow as candidates for election to the £900m investment trust’s board at annual general meeting in November. This […]
